Rock Out like It’s the 00s
    Listen Now
    .

    NEW YORK (Reuters) - Allergan Plc on Friday announced positive results from a second Phase III trial for the 50 milligram dose of its drug for acute migraine, reproducing results from the previous trial.

    .
    .
    .